EW Radue

1.1k total citations
15 papers, 669 citations indexed

About

EW Radue is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Rheumatology. According to data from OpenAlex, EW Radue has authored 15 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 3 papers in Molecular Biology and 3 papers in Rheumatology. Recurrent topics in EW Radue's work include Multiple Sclerosis Research Studies (10 papers), Sphingolipid Metabolism and Signaling (3 papers) and Acute Lymphoblastic Leukemia research (2 papers). EW Radue is often cited by papers focused on Multiple Sclerosis Research Studies (10 papers), Sphingolipid Metabolism and Signaling (3 papers) and Acute Lymphoblastic Leukemia research (2 papers). EW Radue collaborates with scholars based in Switzerland, United States and Canada. EW Radue's co-authors include Ludwig Kappos, Stefan Borgwardt, Xavier Montalbán, Ana de Vera, Anita Riecher‐Rössler, Paul O’Connor, Jack P. Antel, Giancarlo Comi, H. Pöhlmann and Paul Allen and has published in prestigious journals such as Neurology, Journal of the Neurological Sciences and Current Pharmaceutical Design.

In The Last Decade

EW Radue

14 papers receiving 653 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
EW Radue Switzerland	9	330	159	155	143	142	15	669
Le H. Hua United States	13	331 1.0×	154 1.0×	89 0.6×	64 0.4×	190 1.3×	44	773
Léorah Freeman United States	13	454 1.4×	66 0.4×	207 1.3×	63 0.4×	135 1.0×	38	791
Anna M. Pietroboni Italy	22	289 0.9×	70 0.4×	331 2.1×	153 1.1×	81 0.6×	52	1.1k
L Metz Canada	12	411 1.2×	122 0.8×	82 0.5×	75 0.5×	28 0.2×	17	739
Ryszard Podemski Poland	14	220 0.7×	78 0.5×	61 0.4×	85 0.6×	49 0.3×	65	540
Rozie Arnaoutelis Canada	5	546 1.7×	64 0.4×	149 1.0×	52 0.4×	174 1.2×	6	795
David Paling United Kingdom	14	446 1.4×	36 0.2×	94 0.6×	67 0.5×	146 1.0×	35	732
O Lyon-Caen France	12	387 1.2×	48 0.3×	90 0.6×	135 0.9×	76 0.5×	35	835
Burcu Zeydan United States	16	360 1.1×	36 0.2×	84 0.5×	67 0.5×	76 0.5×	45	676
Francesca Vitetta Italy	18	288 0.9×	120 0.8×	103 0.7×	29 0.2×	36 0.3×	36	744

Countries citing papers authored by EW Radue

Since Specialization

Citations

This map shows the geographic impact of EW Radue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by EW Radue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites EW Radue more than expected).

Fields of papers citing papers by EW Radue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by EW Radue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by EW Radue. The network helps show where EW Radue may publish in the future.

Co-authorship network of co-authors of EW Radue

This figure shows the co-authorship network connecting the top 25 collaborators of EW Radue. A scholar is included among the top collaborators of EW Radue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with EW Radue. EW Radue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Schmidt, André, Niklaus Denier, Stefano Magon, et al.. (2015). Increased functional connectivity in the resting-state basal ganglia network after acute heroin substitution. Translational Psychiatry. 5(3). e533–e533. 36 indexed citations

Sormani, Maria Pia, Nicola De Stefano, G. Francis, et al.. (2015). Fingolimod effect on brain volume loss independently contributes to its effect on disability. Multiple Sclerosis Journal. 21(7). 916–924. 31 indexed citations

Xiu, Zhang, EW Radue, K. Beckmann, et al.. (2014). Interferon beta-1b is effective and has a favourable safety profile in Chinese patients with relapsing forms of multiple sclerosis.

Kappos, Ludwig, EW Radue, G. Comi, et al.. (2013). Disease control and safety in relapsing remitting multiple sclerosis (RRMS) patients switching from natalizumab to fingolimod: a 32-week, rater- and patient-blind, randomized, parallel-group study (TOFINGO). Multiple Sclerosis Journal. 19(11). 7 indexed citations

Izquierdo, Guillermo, Paul O’Connor, Xavier Montalbán, et al.. (2013). Five-year results from a phase 2 study of oral fingolimod in relapsing multiple sclerosis. Multiple Sclerosis Journal. 20(7). 877–881. 19 indexed citations

Kappos, L, EW Radue, P. O’Connor, et al.. (2012). Long-Term Efficacy and Safety of Fingolimod (FTY720) in Relapsing-Remitting Multiple Sclerosis (RRMS): Results from the Extension of the Phase III FREEDOMS Study (S41.004). Neurology. 78(Meeting Abstracts 1). S41.004–S41.004. 10 indexed citations

Jafari, Naghmeh, Kerstin Bendfeldt, Nicole Mueller‐Lenke, et al.. (2011). No influence of KIF1B on neurodegenerative markers in multiple sclerosis. Neurology. 76(21). 1843–1845. 3 indexed citations

Schlaeger, Regina, Marcus D’Souza, Christian Schindler, et al.. (2011). Prediction of long-term disability in multiple sclerosis. Multiple Sclerosis Journal. 18(1). 31–38. 46 indexed citations

Gloor, M, Oliver Bieri, Stefan T. Engelter, et al.. (2010). Quantitative Magnetization Transfer Imaging in Acute Stroke: A Follow Up Study Correlating Quantitative MRI with Respect of Severity of Stroke. MPG.PuRe (Max Planck Society). 3 indexed citations

10.

Smieskova, Renata, Paolo Fusar‐Poli, Paul Allen, et al.. (2009). The Effects of Antipsychotics on the Brain: What Have We Learnt from Structural Imaging of Schizophrenia? – A Systematic Review. Current Pharmaceutical Design. 15(22). 2535–2549. 171 indexed citations

11.

O’Connor, Paul, Giancarlo Comi, Xavier Montalbán, et al.. (2009). Oral fingolimod (FTY720) in multiple sclerosis. Neurology. 72(1). 73–79. 149 indexed citations

12.

Stone, L., June Halper, J. Simón, et al.. (2009). FP14-TU-01 Consortium of multiple sclerosis centers (CMSC) guidelines for a standardized MRI protocol for the diagnosis and follow-up of multiple sclerosis: 2009 revision. Journal of the Neurological Sciences. 285. S78–S79. 2 indexed citations

13.

Sailer, Michael, Franz Fazekas, Achim Gass, et al.. (2008). Zerebrale und spinale MRT-Untersuchung bei Patienten mit klinisch isoliertem Syndrom oder gesicherter Multipler Sklerose. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 180(11). 994–1001. 6 indexed citations

14.

Kappos, Ludwig, Michel Clanet, Magnhild Sandberg‐Wollheim, et al.. (2005). Neutralizing antibodies and efficacy of interferon β-1a. Neurology. 65(1). 40–47. 154 indexed citations

15.

Wiesner, W., et al.. (2001). Swallowing abnormalities in multiple sclerosis: correlation between videofluoroscopy and subjective symptoms. European Radiology. 12(4). 789–792. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact